SHARE
Facebook X Pinterest WhatsApp

Patent Reform Battle Shifts to Senate

Written By
thumbnail
Roy Mark
Roy Mark
Oct 25, 2007

Having failed to stop patent reform in the U.S. House of Representatives, opponents are now focusing on the Senate.

In a letter sent Tuesday to Senate leaders, more than 400 organizations ranging from biotech to grocers urged lawmakers to make significant changes to legislation approved on Sept. 7 by the House.

With a similar version to the House bill already approved by the Senate Judiciary Committee, the letter said the current legislation will create “uncertainty and weaken” the enforceability of validly issued patents.

“No compelling case has been made for a bill written in this fashion. It is based on claims of a crisis in the current patent system that does not exist, supported by selective assertions which do not hold up under scrutiny,” the letter states. “We believe the authors of the legislation must make fundamental changes to the legislation if it is to work for all American innovators.”

Strongly supported by the technology industry, the House bill narrows the definition of willful infringement and limits infringement damage awards to the actual value of the technology involved instead of the overall value of a completed product.

The bill, passed on a 225-175 vote, also creates a “second window” to challenge patents issued by the Patent and Trademark Office. In addition, the legislation would create a first-inventor-to-file system to replace the current first-to-invent standard, moving the United States closer to international standards.

“Some of the proposed reform provisions, such as an expanded apportionment of damages, [and] an indefinite post-grant opposition process…pose serious negative consequences for continued innovation and American technological leadership in a competitive global economy,” the letter states.

House and Senate leaders have repeatedly stressed that the legislation is a work in progress, promising opponents the final version will incorporate changes aimed at appeasing the concerns of the biotechnology, pharmaceutical and manufacturing industries.

“We admit this bill isn’t perfect,” bill co-sponsor Howard Berman, D-Calif., chairman of the House Courts, Internet and Intellectual Property Subcommittee, said Sept. 7. “This is really complicated stuff. We will continue working for compromise.”

Rep. John Conyers, D-Mich., chairman of the House Judiciary Committee, also called the bill a work in progress. “We made changes to accommodate the minority side and it won’t be final until we come out of conference [with the Senate].”

Recommended for you...

What do Amazon, Microsoft, Meta, and IBM Have in Common? Tape Storage
Drew Robb
Aug 15, 2022
What Does Quantum Computing Mean for IT?
Devin Partida
Aug 11, 2022
Solving the Video Surveillance Retention Challenge 
Drew Robb
Jul 28, 2022
Top 6 IT Challenges in Healthcare
Lauren Hansen
Jun 21, 2022
CIO Insight Logo

CIO Insight offers thought leadership and best practices in the IT security and management industry while providing expert recommendations on software solutions for IT leaders. It is the trusted resource for security professionals who need to maintain regulatory compliance for their teams and organizations. CIO Insight is an ideal website for IT decision makers, systems integrators and administrators, and IT managers to stay informed about emerging technologies, software developments and trends in the IT security and management industry.

Property of TechnologyAdvice. © 2025 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.